Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

Marie Skłodowska-Curie Action · Running

ImmunoGBMet Understanding iNKT cell Metabolic features in GlioBlastoMa tumours to improve Immunotherapy

Coordinator
The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin, Ireland
Runs
1 October 2023 to 30 September 2025
Status
Running
EU funding
€200k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101108116

What the project is doing

In the project's own words, from its summary on CORDIS.

Glioblastoma (GBM) is one of the most aggressive and fatal types of tumours with one of the worse survival rates. Although immunotherapy is a remarkable and fast-growing field on cancer treatment it still faces the challenge that solid tumours are very suppressive for immune cells. This suppressive tumour microenvironment (TME) is known to affect immune cells in different ways, as through the expression of inhibitory ligands and cytokines.

Recently, it has been shown that lipids and other metabolites are increased in the TME and affect metabolic pathways in immune cells leading to their dysfunction. NKT cells are a distinct subset of lymphocytes that react to lipids presented via the CD1d molecule and produce a range of cytokines upon activation. They play a role in tumoral immunity either through cytotoxicity or by activating other cytotoxic lymphocytes.

However, little is known about their function in the GBM tumour and how the TME affects it. This project will leverage expertise in immunometabolism to describe the alterations in NKT cell metabolism that lead to their dysfunction in the GBM TME. We will take advantage of single-cell metabolic tools and proteomics analysis to unveil the most altered pathways, then, set up the best approaches to engineer NKT cells and make them resistant to the adverse TME.

Our findings will potentially pave the way to new strategies on engineering immune cells for cancer immunotherapy and other serious conditions.

Topics

Who is involved

OrganisationCityCountryRole
The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near DublinDublinIrelandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI